Project on neuroblastoma 

This project follows the results obtained in our previous study on the ATM gene, which is now focusing on the study of the efficacy of a recently discovered molecule, PRIMA-1MET, which can act against neuroblastoma, an extra solid cranial tumor which accounts for 8 to 10% of all pediatric cancers. In-depth preclinical research is needed before proceeding to clinical assessment that will provide essential data for new treatment strategies.